Security key
44486Q111
- Security type / class
- Equity / *W EXP 08/27/202
- Total 13F shares
- 721,848
- Total 13F value
- $808,000
- Share change
- -209,341
- SEC-reported price per share
- $1.11
- Number of holders
- 9
- Value change
- -$187,249
- Number of buys
- 1
- Number of sells
- 3
Report period
Q3 2022
Institutions
9
Top holders
9
HUMAW full security history
Ownership snapshot
Full 13F holder table
Humacyte, Inc. SEC filings
Humacyte, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of HUMAW - Humacyte, Inc. - *W EXP 08/27/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRESENIUS MEDICAL CARE HO...
Disclosed value leader
FRESENIUS MEDICAL CARE HO...
Comparable rows
0/15
Latest evidence
30 Jun 2022
3/4/5
13F
Highest disclosed value: $21,792,154
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ has the largest disclosed position value at $21.79M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.
Disclosed position value
Top 5
FRESENIUS MEDICAL CARE HOLDINGS I...
$21.79M
VANGUARD GROUP INC
$8.58M
BlackRock Finance, Inc.
$7.69M
York Capital Management Global Ad...
$7.36M
OCONNOR, A Distinct Business Unit...
$3.53M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ |
3/4/5
Former 10% Shareholder
|
—
denominator unverified
|
$21,792,154
18,312,735 shares
|
— | 26 Aug 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$8,584,000
2,674,005 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$7,693,000
2,396,378 shares
|
— | 30 Jun 2022 |
| York Capital Management Global Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$7,355,000
2,291,397 shares
|
— | 30 Jun 2022 |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
Company
|
—
denominator unverified
|
$3,531,000
1,100,000 shares
|
— | 30 Jun 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$2,497,000
777,997 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
721,848
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
9
Q3 2022 holders
9
Holder diff
0
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|